NewGenIvf Group (NIVF) Competitors $0.28 -0.01 (-4.41%) Closing price 03:59 PM EasternExtended Trading$0.27 0.00 (-1.09%) As of 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. BGLC, ACON, ATIP, DHAC, VSEE, BACK, BTTX, UPHL, ACONW, and AONCShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include BioNexus Gene Lab (BGLC), Aclarion (ACON), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), Vsee Health (VSEE), IMAC (BACK), Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), and American Oncology Network (AONC). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. BioNexus Gene Lab Aclarion ATI Physical Therapy Digital Health Acquisition Vsee Health IMAC Better Therapeutics UpHealth Aclarion American Oncology Network BioNexus Gene Lab (NASDAQ:BGLC) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation. Does the MarketBeat Community prefer BGLC or NIVF? BioNexus Gene Lab and NewGenIvf Group both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBioNexus Gene LabN/AN/ANewGenIvf GroupN/AN/A Do insiders & institutionals believe in BGLC or NIVF? 18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 0.7% of BioNexus Gene Lab shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is BGLC or NIVF more profitable? NewGenIvf Group has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -10.17%. NewGenIvf Group's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets BioNexus Gene Lab-10.17% -9.93% -8.43% NewGenIvf Group N/A N/A N/A Which has better valuation & earnings, BGLC or NIVF? NewGenIvf Group has lower revenue, but higher earnings than BioNexus Gene Lab. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNexus Gene Lab$9.51M0.53-$2.63MN/AN/ANewGenIvf Group$5.14M0.28$130KN/AN/A Which has more risk & volatility, BGLC or NIVF? BioNexus Gene Lab has a beta of 5.41, indicating that its share price is 441% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500. Does the media prefer BGLC or NIVF? In the previous week, BioNexus Gene Lab had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 4 mentions for BioNexus Gene Lab and 3 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 1.43 beat BioNexus Gene Lab's score of 0.59 indicating that NewGenIvf Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioNexus Gene Lab 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NewGenIvf Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNewGenIvf Group beats BioNexus Gene Lab on 7 of the 11 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.45M$1.98B$5.47B$7.92BDividend YieldN/A7.12%5.11%4.22%P/E RatioN/A15.9322.5118.54Price / Sales0.283.76397.62103.35Price / Cash3.119.3238.1834.62Price / Book0.133.986.734.25Net Income$130,000.00$87.49M$3.22B$248.18M7 Day Performance-23.48%-1.07%1.58%1.25%1 Month Performance-54.55%-5.61%4.05%3.76%1 Year Performance-99.14%-26.48%15.75%5.28% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf Group1.9104 of 5 stars$0.28-4.4%N/A-99.2%$1.45M$5.14M0.00N/AShort Interest ↓Positive NewsGap UpHigh Trading VolumeBGLCBioNexus Gene Lab0.2659 of 5 stars$2.67-2.2%N/A-54.0%$4.80M$9.26M0.0030Short Interest ↑News CoverageGap DownACONAclarion1.5149 of 5 stars$7.93-11.7%$11,758.50+148,178.7%-99.8%$4.62M$45,724.000.007Gap DownATIPATI Physical TherapyN/A$1.00+17.6%N/A-80.9%$4.41M$741.86M-0.055,600Upcoming EarningsDHACDigital Health AcquisitionN/A$1.19+3.7%N/A-89.7%$4.30MN/A0.002,021VSEEVsee Health1.9186 of 5 stars$1.17-1.9%$5.00+327.4%N/A$4.22M$6.38M0.00N/ABACKIMACN/A$0.05+0.4%N/A-99.0%$94,000.00$72,050.000.00180News CoverageBTTXBetter TherapeuticsN/A$0.00flatN/A-98.5%$20,000.00N/A0.0040UPHLUpHealthN/A$0.00flatN/A-100.0%$4,000.00$130M0.001,750High Trading VolumeACONWAclarionN/A$0.05+9.1%N/A-48.0%$0.00$45,724.000.007Positive NewsAONCAmerican Oncology NetworkN/A$5.11-14.8%N/A+64.9%$0.00$1.34B0.001,520High Trading Volume Related Companies and Tools Related Companies BioNexus Gene Lab Alternatives Aclarion Alternatives ATI Physical Therapy Alternatives Digital Health Acquisition Alternatives Vsee Health Alternatives IMAC Alternatives Better Therapeutics Alternatives UpHealth Alternatives Aclarion Alternatives American Oncology Network Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NIVF Stock Free NIVF Stock Alerts